Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Markusic

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 6, 2020
Immunology of Gene and Cell TherapyDavid M Markusic, Ashley T Martino, Christopher D Porada, et al.
Human Gene Therapy|January 22, 2024
Complement System Response to Adeno-Associated Virus Vector Gene TherapyElizabeth Kropf, David M Markusic, Anna Majowicz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 5, 2011
AAV vector biology in primates: finding the missing link?Roland W Herzog, Andrew M Davidoff, David M Markusic, et al.
Human Gene Therapy|July 17, 2007
Preferential gene transfer of lentiviral vectors to liver-derived cells, using a hepatitis B peptide displayed on GP64David M Markusic, Alexander Kanitz, Ronald P J Oude-Elferink, et al.
Molecular Therapy. Methods & Clinical Development|May 9, 2017
An Immune-Competent Murine Model to Study Elimination of AAV-Transduced Hepatocytes by Capsid-Specific CD8<sup>+</sup> T CellsBrett Palaschak, Damien Marsic, Roland W Herzog, et al.
Frontiers in Immunology|July 17, 2020
B Cell Depletion Eliminates FVIII Memory B Cells and Enhances AAV8-coF8 Immune Tolerance Induction When Combined With RapamycinMoanaro Biswas, Brett Palaschak, Sandeep R P Kumar, et al.
Molecular Therapy. Methods & Clinical Development|June 4, 2016
Clinical development of gene therapy: results and lessons from recent successesSandeep Rp Kumar, David M Markusic, Moanaro Biswas, et al.
Molecular Therapy. Methods & Clinical Development|August 22, 2022
Single-dose AAV vector gene immunotherapy to treat food allergyMiguel Gonzalez-Visiedo, Xin Li, Maite Munoz-Melero, et al.
Molecular Therapy. Methods & Clinical Development|October 15, 2016
Potential for cellular stress response to hepatic factor VIII expression from AAV vectorIrene Zolotukhin, David M Markusic, Brett Palaschak, et al.
BMC Biotechnology|October 9, 2009
Reduction of liver macrophage transduction by pseudotyping lentiviral vectors with a fusion envelope from Autographa californica GP64 and Sendai virus F2 domainDavid M Markusic, Niek P van Til, Johan K Hiralall, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 6, 2020
Immunology of Gene and Cell TherapyDavid M Markusic, Ashley T Martino, Christopher D Porada, et al.
Human Gene Therapy|January 22, 2024
Complement System Response to Adeno-Associated Virus Vector Gene TherapyElizabeth Kropf, David M Markusic, Anna Majowicz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 5, 2011
AAV vector biology in primates: finding the missing link?Roland W Herzog, Andrew M Davidoff, David M Markusic, et al.
Human Gene Therapy|July 17, 2007
Preferential gene transfer of lentiviral vectors to liver-derived cells, using a hepatitis B peptide displayed on GP64David M Markusic, Alexander Kanitz, Ronald P J Oude-Elferink, et al.
Molecular Therapy. Methods & Clinical Development|May 9, 2017
An Immune-Competent Murine Model to Study Elimination of AAV-Transduced Hepatocytes by Capsid-Specific CD8<sup>+</sup> T CellsBrett Palaschak, Damien Marsic, Roland W Herzog, et al.
Frontiers in Immunology|July 17, 2020
B Cell Depletion Eliminates FVIII Memory B Cells and Enhances AAV8-coF8 Immune Tolerance Induction When Combined With RapamycinMoanaro Biswas, Brett Palaschak, Sandeep R P Kumar, et al.
Molecular Therapy. Methods & Clinical Development|June 4, 2016
Clinical development of gene therapy: results and lessons from recent successesSandeep Rp Kumar, David M Markusic, Moanaro Biswas, et al.
Molecular Therapy. Methods & Clinical Development|August 22, 2022
Single-dose AAV vector gene immunotherapy to treat food allergyMiguel Gonzalez-Visiedo, Xin Li, Maite Munoz-Melero, et al.
Molecular Therapy. Methods & Clinical Development|October 15, 2016
Potential for cellular stress response to hepatic factor VIII expression from AAV vectorIrene Zolotukhin, David M Markusic, Brett Palaschak, et al.
BMC Biotechnology|October 9, 2009
Reduction of liver macrophage transduction by pseudotyping lentiviral vectors with a fusion envelope from Autographa californica GP64 and Sendai virus F2 domainDavid M Markusic, Niek P van Til, Johan K Hiralall, et al.
Pageof 5